UCSF

Tagged: Research

Wearable device monitors heart failure

A new study published in Circulation: Heart Failure shows how bioengineers are teaming up with clinicians to improve patient outcomes.

Is "Junk DNA" What Makes Humans Unique?

Scientific American

Hiding in plain sight

A tiny implant promises to simplify how glaucoma drugs are administered, making life easier for aging patients.

A Quest: Insulin-Releasing Implant For Type-1 Diabetes

NPR: Health Shots

Novel diabetes treatment developed in Desai Lab to power SF-area startup

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

The biotechnology company Encellin acquired exclusive worldwide rights to the technology, originally developed in the laboratory of Tejal Desai, PhD, chair of the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine.

Wired magazine visits The Kidney Project

Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.

Update from the Dean - September 2017

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership; Tobacco burden in vulnerable populations; Economics of disease; Precision medicine.

Pages